Helen K. Ellias - Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Helen K. Ellias since 9/18/2023

Holdings reported by Helen K. Ellias for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.86M $2.51M $0.88 Nov 24, 2023 Indirect
Series A-1 Convertible Preferred Stock 0 $1,000.00 Nov 24, 2023 Indirect Common Stock or Series A-2 Convertible Preferred Stock

Transactions reported by Helen K. Ellias for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.